Hyaluronic Acid Fillers and ASIA Syndrome: Case Studies [Erratum]

This article refers to:

Hyaluronic Acid Fillers and ASIA Syndrome: Case Studies

Owczarczyk-Saczonek A, De Boulle K. Clin Cosmet Investig Dermatol. 2023;16: 2763-2771.

It has come to our attention that Table 1 cited on pages 2764 and 2768 was missed from being included in the published proof. The journal wishes to apologise for this error. The intended Table 1 is as follows.

Table 1 Clinical Charakteristics of Our patients with ASIA syndrome

	Case 1	Case 2	Case 3
Major criteria	Muscle pain, muscle weakness Joint pain Chronic fatigue, sleep disturbances Memory loss	Muscle pain, muscle weakness Joint pain Chronic fatigue, sleep disturbances Biopsy of the skin: necrotizing arteritis in small and medium-size arteries with granulocytes and mononuclear cells in the vessel wall	Muscle pain, muscle weakness Joint pain Chronic fatigue, sleep disturbances
Minor criteria	Positive ANA, anti-thyroid antibodies Development of autoimmune thyroiditis	Development of polyartheritis nodosa and vasculitis	Positive ANA
Exposure to other adjuvants or predisposing factors	Father suffered from SLE (probably genes predisposition)	For 3 years injection of collagen-based products and HA fillers Anti-Covid vaccinations	Psoriasis and psoriatic arthritis, chronic nephritis Anti-psoriatic biologic therapy